Search

Search Constraints

You searched for: Author/Creator Razak, Albiruni Abdul

Search Results

1. 291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors. (9th November 2020)

2. Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck. (February 2019)

3. Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities. Issue 8 (15th February 2019)

4. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Issue 34 (1st December 2022)